Interviewer-Administered followed by Self-Administration for Alcohol Abuse
Phase-Based Progress Estimates
Effectiveness
Safety
Baylor Scott and White Community Care, Dallas, TX
Alcohol Abuse+5 More
Screening - OtherEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
The goal of this study is to validate the TAPS-ESP as a screen and assessment that can be used in primary care for the screening and treatment of substance use.
Eligible Conditions
- Alcohol Abuse
- Drug abuse
- Tobacco Use
- Substance Use
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 5 Secondary · Reporting Duration: 1 year
1 year
Alcohol Use Disorders Identification Test (AUDIT) for concurrent and convergent validity of the TAPS
Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) for concurrent and convergent validity of the TAPS Tool
CAGE (Cut Down, Annoyed, Guilty, Eye-Opener) for concurrent and convergent validity of the TAPS
Drug Abuse Screening Test (DAST-10) for concurrent and convergent validity of the TAPS Tool
Fagerstrom Test for Nicotine Dependence (FTND) for concurrent and convergent validity of the TAPS
Tobacco, Alcohol, Prescription drug, and illicit Substance Use Tool-Electronic Spanish Platform (TAPS-ESP) primary criterion validation against the modified World Mental Health Composite International Diagnostic Interview (CIDI) in Spanish
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Interviewer-Administered followed by Self-Administration
1 of 2
Self-Administration followed by Interviewer-Administered
1 of 2
Active Control
1000 Total Participants · 2 Treatment Groups
Primary Treatment: Interviewer-Administered followed by Self-Administration · No Placebo Group · N/A
Interviewer-Administered followed by Self-Administration
Other
ActiveComparator Group · 1 Intervention: Screening · Intervention Types: OtherSelf-Administration followed by Interviewer-Administered
Other
ActiveComparator Group · 1 Intervention: Screening · Intervention Types: OtherTrial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year
Closest Location: Baylor Scott and White Community Care · Dallas, TX
N/AFirst Recorded Clinical Trial
1 TrialsResearching Alcohol Abuse
0 CompletedClinical Trials
Who is running the clinical trial?
COG AnalyticsOTHER
2 Previous Clinical Trials
130 Total Patients Enrolled
Baylor Research InstituteLead Sponsor
187 Previous Clinical Trials
185,186 Total Patients Enrolled
Katherine Sanchez, PhDPrincipal InvestigatorBaylor Scott and White Research Institute
2 Previous Clinical Trials
500 Total Patients Enrolled
Eligibility Criteria
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments